Ready To Welcome To...
Health Care: Drugs
MannKind Corporation (MNKD: NASDAQ)
$6.55 -0.30 | -4.38%
05/24/13 - 04:00 PM ET
Latest Dividend:0.00
Latest Dividend Yield:0.00%
Dividend Ex-Date:12/31/69
Price Earnings Ratio:n/a
Price Earnings Comparisons:
| MNKD | Sector Avg. | S&P 500 |
|---|---|---|
| n/a | 0.00 | 17.70 |
Price Performance History (% change):
| 3 Mo | 1 Yr | 3 Yr |
|---|---|---|
| 169.69 | 301.84 | 38.38 |
| GROWTH | 12 Mo | 3 Yr | CAGR |
|---|---|---|---|
| Revenue | -30.00 | 0.00 | 0.00 |
| Net Income | 0.00 | 0.00 | |
| EPS | -0.55 | 0.00 |
Earnings for MNKD:
| EBITDA | -146.00 |
| REVENUE | 35.00K |
Average Earnings Estimates
| Qtr (06/13) | Qtr (09/13) | FY (12/13) | FY (12/14) | |
|---|---|---|---|---|
| Average Estimate | $-0.15 | $-0.13 | $-0.49 | $-0.22 |
| Number of Analysts | 4 | 3 | 5 | 4 |
| High Estimate | $-0.13 | $-0.12 | $-0.39 | $-0.14 |
| Low Estimate | $-0.17 | $-0.15 | $-0.54 | $-0.37 |
| Prior Year | $-0.23 | $-0.22 | $-0.94 | $-0.49 |
| Growth Rate (Year over Year) | 36.96% | 39.39% | 47.45% | 55.97% |
Portfolios with MNKD
- Portfolio NameUser Type
- ContributorMost-Active Stocks for the ...
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Setting Up...
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks With Big Insider Buy...
- Userbiomed
- ContributorStocks Under-$10 Setting Up...
- ContributorStocks Under-$10 Moving Hig...
- UserHoldings
- Contributor10 Most Shorted Stocks in B...
Latest MNKD Headlines from TheStreet
- MannKind Stock Falls On Unusually High Volume (MNKD) 05.24.13 | 03:05 pm
- Biotech Stock Mailbag: Amarin, MannKind, Palatin 05.24.13 | 07:05 am
- Commit To Buy MannKind Corp At $2.50, Earn 28% 05.23.13 | 02:05 pm
- MannKind's Mysterious Lung-Safety Study Is Open But Shhh...Don't Talk About It 04.17.13 | 09:04 am
- Biotech Stock Mailbag: Exact Sciences, Galena, Titan, Arena, Breakthrough Therapy 04.12.13 | 06:04 am
- 3 Highly Shorted Stocks Under $5 Bought Up By Hedge Funds 04.09.13 | 01:04 pm
- Biotech Stock Mailbag: MannKind, Ariad, Oncolytics Biotech 04.05.13 | 07:04 am
- 8 Stocks Under $5 Seeing Institutional And Insider Buying 04.02.13 | 03:04 pm
- 7 Biotechnology Stocks With Insider Buying Activity 03.20.13 | 10:03 am
- 10 Stocks Insiders And Hedge Funds Think Will Go Higher 03.11.13 | 01:03 pm
Press Releases for MNKD
- MannKind Corporation To Present At The Cowen And Company 33rd Annual Health Care Conference - Business Wire 02.26.13 | 05:02 pm
- MannKind Corporation Reports 2012 Fourth Quarter And Full Year Financial Results - Business Wire 02.11.13 | 04:02 pm
- MannKind Corporation To Hold 2012 Fourth Quarter And Full Year Financial Results Conference Call On February 11, 2013 - Business Wire 02.04.13 | 05:02 pm
- MannKind Corporation To Present At The 31st Annual J.P. Morgan Healthcare Conference - Business Wire 01.03.13 | 05:01 pm
- MannKind Corporation To Present At The 24th Annual Piper Jaffray Healthcare Conference - Business Wire 11.20.12 | 05:11 pm
- Faruqi & Faruqi, LLP Launches An Investigation Against Mannkind Corp. (MNKD) For Potential Breaches Of Fiduciary Duties By Its Board Of Directors - Business Wire 11.19.12 | 07:11 pm
- Colby And MannKind Sign License And Joint Development Agreement To Develop And Commercialize Cancer Immunotherapy Products - Business Wire 11.13.12 | 08:11 am
- MannKind Corporation Reports 2012 Third Quarter Financial Results - Business Wire 11.01.12 | 04:11 pm
- MannKind Corporation Reschedules 2012 Third Quarter Financial Results Conference Call To November 1, 2012 Due To Hurricane Sandy - Business Wire 10.29.12 | 02:10 pm
- MannKind Corporation To Hold 2012 Third Quarter Financial Results Conference Call On October 29, 2012 - Business Wire 10.22.12 | 06:10 pm
Partner Headlines for MNKD
- Market Wrap for Wednesday, May 22: Stocks Pullback As Bernanke Says Bond Buying Could Slow - Benzinga 05.22.13 | 04:05 pm
- Mid-Afternoon Market Update: MannKind Posts Huge Rally as Markets Plummet - Benzinga 05.22.13 | 04:05 pm
- U.S. Steel, Genomic Health and Other Stocks Insiders Are Buying - Benzinga 05.18.13 | 03:05 pm
- Why MannKind's Afrezza Will Succeed Where Pfizer Failed - Seeking Alpha 05.18.13 | 04:05 am
- Mid-Afternoon Market Update: Markets Remain Down, Bankrate Rallies - Benzinga 04.12.13 | 03:04 pm
- Long MannKind's Afrezza: Shares Versus A Bull Call Spread - Seeking Alpha 12.01.12 | 07:12 am
- MannKind to Raise Funds - Analyst Blog - Zacks 10.18.12 | 07:10 pm
- MannKind Announces Pricing of Public Offering of Common Stock and Warrants - Benzinga 10.18.12 | 09:10 am
- MNKD Enrolls Patients for Afrezza - Analyst Blog - Zacks 10.08.12 | 06:10 pm
- Company News for September 05, 2012 - Corporate Summary - NASDAQ 09.05.12 | 02:09 pm
